Pentoxifylline EP Impurity J

Research on impurity of pentoxifylline and glucose injection
B.-Y. Du, Z. Wang
Journal of Chinese Pharmaceutical Sciences 49(9):773-775
 
Simultaneous determination of pentoxifylline and its impurities in tablet dosage forms by RP-HPLC
Boyka G. Tsvetkova, Ivanka P. Pencheva, Plamen T. Peikov
Der Pharma Chemica, 2012, 4 (2):608-612
 
Development of a HPTLC method for in‐process purity testing of pentoxifylline
Olivera Grozdanovic  Dusan Antic  Danica Agbaba
Journal of separation science Volume28, Issue6 April 2005 Pages 575-580
 
A validated stability indicating DAD–HPLC method for determination of pentoxifylline in presence of its pharmacopeial related substances
Mohamed A.Korany, Rim S.Haggag, Marwa A.A.Ragab, Osama A.Elmallah

Pentoxifylline EP Impurity J is chemically 1-[(5E)-11-(3,7-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-1-yl)-5-methyl-7-oxoundec-5-enyl]-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione. Pentoxifylline EP Impurity J is supplied with detailed characterization data compliant with regulatory guideline. Pentoxifylline EP Impurity J can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Pentoxifylline.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.